Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome | Zendy

Sven M. Carlsen | Zendy; Eszter Vanky | Zendy; R. Fleming | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

Author(s) -

Sven M. Carlsen,

Eszter Vanky,

R. Fleming

Publication year - 2009

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dep074

Subject(s) - polycystic ovary , anti müllerian hormone , medicine , endocrinology , testosterone (patch) , androgen , metformin , antral follicle , placebo , hormone , insulin resistance , insulin , alternative medicine , pathology

Current data suggest that excessive androgen exposure can lead to the development of polycystic ovaries and polycystic ovary syndrome (PCOS). Anti-Müllerian hormone (AMH) levels reflect the number of small antral follicles in the ovaries and are elevated in PCOS. We hypothesized that protracted reduction of circulating androgens and/or insulin resistance would reduce circulating AMH concentrations in women with PCOS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research